1. Department of Medicine, Moores Cancer Center, University of California, San Diego, San Diego, CA;
2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;
3. Bioinformatics and Systems Biology, University of California, San Diego, San Diego, CA;
4. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard University, Boston, MA;
5. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
6. Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, NY;
7. Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN;
8. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University, Boston, MA;
9. Division of Hematology and Comprehensive Cancer Center, The Ohio State University, Columbus, OH;
10. Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; and
11. Moores Cancer Center, Department of Pediatrics and Rady Children's Hospital, Institute for Genomic Medicine, Chronic Lymphocytic Leukemia Research Consortium, University of California, San Diego, San Diego, CA